VNRX

Conviction 62HealthcareScan · Thu, Jun 25, 2026

VNRX$1.30+5.69%

ResistanceSupportVol 14

Vol MA14 396.98K

Mar 26Apr 14May 1May 19Jun 8Jun 25

VOLITIONRX LTDIN VITRO & IN VIVO DIAGNOSTIC SUBSTANCESwww.volition.com ↗

Price1.30

Change+5.69%

Gap-0.41%

Rel volume0.41×

Avg volume372.46K

Avg $ vol610.51K

SMA 201.70

SMA 501.75

SMA 2000.6906

Price vs 50-25.82%

Price vs 200+88.25%

MA stackmixed

50/200 cross—

Supertrenddown · 1.79

RSI (14)38

MACD hist-0.06

MACD cross—

Stoch %K / %D15 / 7

ADX (14)26

+DI / −DI19 / 30

RSI divergence—

MACD divergence—

ATR %+15.11%

ADR %10.64%

52w high3.13

52w low0.1362

From 52w high-58.47%

Above 52w low+854.48%

New 52w highNo

SqueezeOff

Bollinger width122.17%

%B0.31

Donchian pos7.30%

Donchian high2.95

Donchian low1.17

AVWAP (52w high)1.87

vs AVWAP high-30.43%

AVWAP (52w low)1.85

vs AVWAP low-29.61%

OBV trendDown

Chaikin MF (20)-0.39

Today vs 20d0.41×

Avg vol (14d)396.98K

Avg vol (20d)372.46K

Avg $ vol (20d)610.51K

Market cap10.83M

RS 3m (vs SPY)+499.38%

RS 6m (vs SPY)+372.73%

RS line new highNo

Trend template6/8

Technical rank61.7

1 week-5.11%

1 month-55.78%

3 months+579.56%

6 months+385.98%

1 year+68.44%

YTD+376.19%

P/E-0.46

P/B-0.34

P/S6.27

P/FCF-0.55

EPS-0.3100

Div yield—

ROE73.05%

ROA-258.47%

Debt/Eq-0.23

Current0.33

EV/EBITDA-0.82

Gross margin—

Net margin—

Rev growth40.04%

EPS growth13.39%

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value17M

Revenue985.08K

Net income-6.66M

Gross profit—

Free cash flow-19.77M

IndustryIN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES

ExchangeNYSE

Shares out8.63M

Employees75

ListedWed, Apr 25, 2007

Free float98.87M

Float %72.9%

Short interest389K

Days to cover1.3d

Short volume35.5%

Squeeze score7 / 100

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeB

Conviction62 / 100

Pattern quality—

Tech rank61.7 / 100

Group rank50 / 100

Status laneNo active setup

Setup direction—

Pattern family

Resistance3.02

Support1.60

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in VNRX

All disclosures →

No recent disclosed trades by Congress in VNRX. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in VNRX

No recent insider (Form 4) filings in VNRX. Insiders must file within two business days of a trade.

SEC filings

EDGAR filings in VNRX · 5 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.